Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation

Published:2012-12 Issue:12 Volume:3 Page:e441-e441
ISSN:2041-4889
Container-title:Cell Death & Disease
language:en
Short-container-title:Cell Death Dis

Author:

Fokas E,Prevo R,Pollard J R,Reaper P M,Charlton P A,Cornelissen B,Vallis K A,Hammond E M,Olcina M M,Gillies McKenna W,Muschel R J,Brunner T B

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology

Link

http://www.nature.com/articles/cddis2012181.pdf

Reference49 articles.

1. Hidalgo M . Pancreatic cancer. N Engl J Med 2010; 362: 1605–1617.

2. Raimondi S, Maisonneuve P, Lowenfels AB . Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 2009; 6: 699–708.

3. Ben-Josef E, Lawrence TS . Radiotherapy: the importance of local control in pancreatic cancer. Nat Rev Clin Oncol 2012; 9: 9–10.

4. Lim KH, Chung E, Khan A, Cao D, Linehan D, Ben-Josef E et al. Neoadjuvant therapy of pancreatic cancer: the emerging paradigm? Oncologist 2012; 17: 192–200.

5. Brunner TB, Scott-Brown M . The role of radiotherapy in multimodal treatment of pancreatic carcinoma. Radiat Oncol 2010; 5: 64.

Cited by 298 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Particle Beam Radiobiology Status and Challenges: A PTCOG Radiobiology Subcommittee Report;International Journal of Particle Therapy;2024-09

2. Identification of epigenetic modifiers essential for growth and survival of AML1/ETO‐positive leukemia;International Journal of Cancer;2024-08-15

3. Distinct regulation of ATM signaling by DNA single-strand breaks and APE1;Nature Communications;2024-08-07

4. Chemo-Phosphoproteomic Profiling with ATR Inhibitors Berzosertib and Gartisertib Uncovers New Biomarkers and DNA Damage Response Regulators;Molecular & Cellular Proteomics;2024-08

5. Dual inhibition of ATR and DNA-PKcs radiosensitizes ATM-mutant prostate cancer;2024-07-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3